Sitagliptin and shock wave-supported peripheral blood derived endothelial progenitor cell therapy effectively preserves residual renal function in chronic kidney disease in rat-role of dipeptidyl peptidase 4 inhibition.

Animals Biomarkers / metabolism Cell- and Tissue-Based Therapy / methods Creatinine / metabolism Dipeptidyl Peptidase 4 / metabolism Dipeptidyl-Peptidase IV Inhibitors / pharmacology Endothelial Progenitor Cells / metabolism Glucagon-Like Peptide 1 / metabolism Hypoglycemic Agents / pharmacology Kidney / drug effects Male Oxidative Stress / drug effects Proteinuria / drug therapy Rats Rats, Sprague-Dawley Renal Insufficiency, Chronic / drug therapy Sitagliptin Phosphate / pharmacology
Chronic kidney disease Endothelial progenitor cells High-protein diet Shock wave Sitagliptin

Journal

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
ISSN: 1950-6007
Titre abrégé: Biomed Pharmacother
Pays: France
ID NLM: 8213295

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 11 11 2018
revised: 02 01 2019
accepted: 06 01 2019
entrez: 8 3 2019
pubmed: 8 3 2019
medline: 22 6 2019
Statut: ppublish

Résumé

This study tested whether sitagliptin and shock wave (SW)-assisted circulatory-derived autologous endothelial progenitor cell (EPC) therapy would effectively preserve residual renal function in chronic kidney disease (CKD) induced by 5/6 left-nephrectomy/remove right kidney plus daily feeding high-protein diet (H

Identifiants

DOI: 10.1016/j.biopha.2019.01.025 PMID: 30841422
pubmed: 30841422
pii: S0753-3322(18)38000-4
doi: 10.1016/j.biopha.2019.01.025
pii:
doi:

Substances chimiques

Biomarkers 0
Dipeptidyl-Peptidase IV Inhibitors 0
Hypoglycemic Agents 0
Glucagon-Like Peptide 1 89750-14-1
Creatinine AYI8EX34EU
Dipeptidyl Peptidase 4 EC 3.4.14.5
Sitagliptin Phosphate TS63EW8X6F

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1088-1102

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Auteurs

Pei-Hsun Sung (PH)

Division of Cardiology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, 83301, Taiwan, ROC; Center for Shockwave Medicine and Tissue Engineering, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, 83301, Taiwan, ROC.

Kuan-Hung Chen (KH)

Center for Shockwave Medicine and Tissue Engineering, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, 83301, Taiwan, ROC; Department of Anesthesiology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, 83301, Taiwan, ROC.

Yi-Chen Li (YC)

Division of Cardiology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, 83301, Taiwan, ROC.

John Y Chiang (JY)

Department of Computer Science and Engineering, National Sun Yat-Sen University, Kaohsiung, Taiwan, ROC;; Quanzhou University of Information Engineering, Quanzhou, China.

Mel S Lee (MS)

Department of Orthopedics, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, 83301, Taiwan, ROC. Electronic address: mellee@cgmh.org.tw.

Hon-Kan Yip (HK)

Division of Cardiology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, 83301, Taiwan, ROC; Center for Shockwave Medicine and Tissue Engineering, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, 83301, Taiwan, ROC; Institute for Translational Research in Biomedicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, 83301, Taiwan, ROC; Department of Medical Research, China Medical University Hospital, China Medical University, Taichung, 40402, Taiwan, ROC; Department of Nursing, Asia University, Taichung, 41354, Taiwan, ROC. Electronic address: han.gung@msa.hinet.net.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Meal Timing and Anthropometric and Metabolic Outcomes: A Systematic Review and Meta-Analysis.

Hiu Yee Liu, Ashley A Eso, Nathan Cook et al.
1.00
Humans Meals Time Factors Female Adult

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Sitagliptin and shock wave-supported...
questionsmedicales.fr › Facteurs biologiques › Marqueurs biologiques › Sitagliptin and shock wave-supported...
questionsmedicales.fr › Thérapeutique › Biothérapie › Thérapie cellulaire et tissulaire › Sitagliptin and shock wave-supported...
questionsmedicales.fr › Composés hétérocycliques › Composés hétéromonocycliques › Azoles › Imidazoles › Créatinine › Sitagliptin and shock wave-supported...
questionsmedicales.fr › Facteurs biologiques › Marqueurs biologiques › Antigènes de différenciation › Antigènes de différenciation des lymphocytes T › Dipeptidyl peptidase 4 › Sitagliptin and shock wave-supported...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Effets physiologiques des médicaments › Hypoglycémiants › Inhibiteurs de la dipeptidyl-peptidase IV › Sitagliptin and shock wave-supported...
questionsmedicales.fr › Cellules › Cellules épithéliales › Cellules endothéliales › Progéniteurs endothéliaux › Sitagliptin and shock wave-supported...
questionsmedicales.fr › Hormones gastrointestinales › Peptides glucagon-like › Glucagon-like peptide 1 › Sitagliptin and shock wave-supported...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Effets physiologiques des médicaments › Hypoglycémiants › Sitagliptin and shock wave-supported...
questionsmedicales.fr › Appareil urogénital › Voies urinaires › Rein › Sitagliptin and shock wave-supported...
questionsmedicales.fr › Phénomènes physiologiques › Stress physiologique › Stress oxydatif › Sitagliptin and shock wave-supported...
questionsmedicales.fr › États, signes et symptômes pathologiques › Signes et symptômes › Manifestations urologiques › Protéinurie › Sitagliptin and shock wave-supported...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Rats › Sitagliptin and shock wave-supported...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Rats › Rat Sprague-Dawley › Sitagliptin and shock wave-supported...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Caractéristiques de la maladie › Maladie chronique › Insuffisance rénale chronique › Sitagliptin and shock wave-supported...
questionsmedicales.fr › Composés hétérocycliques › Composés hétéromonocycliques › Pyrazines › Phosphate de sitagliptine › Sitagliptin and shock wave-supported...